To include your compound in the COVID-19 Resource Center, submit it here.

ProQR Therapeutics raises $20M

ProQR Therapeutics N.V. (NASDAQ:PRQR) raised $20 million on Nov. 14 through the sale of 5 million shares in a

Read the full 191 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE